
Market Matters Ep. 12: How HIMS Could Benefit From FDA Changes
Raul Shah, CEO of DocShah Financial, analyzes the potential Wall Street implications of the FDA’s impending decision on peptide regulation, takes a closer look at how Hims & Hers could benefit from approval and shares his health care sector insights. Raul also explains why he still believes in UnitedHealth and why he’ll always be a value investor. ======== Schwab Network ======== Empowering every investor and trader, every market day. Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribe Download the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185 Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7 Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watch Watch on Vizio - https://www.vizio.com/en/watchfreeplus-explore Watch on DistroTV - https://www.distro.tv/live/schwab-network/ Follow us on X – https://twitter.com/schwabnetwork Follow us on Facebook – https://www.facebook.com/schwabnetwork Follow us on LinkedIn - https://www.linkedin.com/company/schwab-network/ About Schwab Network - https://schwabnetwork.com/about
Publisher
Market Matters with Marley Kayden
Link
podcasters.spotify.com/pod/show/schwab-network2/episodes/Market-Matters-Ep--12-How-HIMS-Could-Benefit-From-FDA-Changes-e3mue9d
Published
August 4, 2026
Duration
45 min
Format
Podcast
Category
News · Business News
Source
RSS feed
Host
Schwab Network
Market Matters with Marley Kayden
@marketmatterswithmarleykayde
#marketmattersep #benefit #fdachanges
